Mirae Asset Global Investments Co., Ltd. Eye Point Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 2,658 shares of EYPT stock, worth $27,776. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,658
Previous 2,251
18.08%
Holding current value
$27,776
Previous $12,000
108.33%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding EYPT
# of Institutions
167Shares Held
71.7MCall Options Held
232KPut Options Held
207K-
Cormorant Asset Management, LP Boston, MA8.33MShares$87 Million4.79% of portfolio
-
Suvretta Capital Management, LLC New York, NY6.8MShares$71.1 Million1.61% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA6.2MShares$64.8 Million0.07% of portfolio
-
Franklin Resources Inc San Mateo, CA4.15MShares$43.4 Million0.01% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA4.09MShares$42.7 Million0.05% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $356M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...